Harpoon Therapeutics, Inc.
FLT3 binding proteins and methods of use

Last updated:

Abstract:

Provided herein are FLT3 binding proteins, pharmaceutical compositions comprising such proteins or fragments thereof, as well as nucleic acids, recombinant expression vectors and host cells for making such FLT3 binding proteins. Also disclosed are methods of using the disclosed FLT3 binding proteins in the prevention, and/or treatment of diseases, conditions and disorders.

Status:
Grant
Type:

Utility

Filling date:

19 Feb 2021

Issue date:

23 Nov 2021